Invention Grant
- Patent Title: Subgroup B recombinant human adenovirus vector, and methods for constructing and for using the same
-
Application No.: US15904408Application Date: 2018-02-25
-
Publication No.: US10294493B2Publication Date: 2019-05-21
- Inventor: Yaohe Wang , Guozhong Jiang , Hanshi Wong , Fengyu Cao , Nick Lemoine
- Applicant: Beijing Bio-Targeting Therapeutics Technology Inc.
- Applicant Address: CN Beijing
- Assignee: BEIJING BIO-TARGETING THERAPEUTICS TECHNOLOGY INC.
- Current Assignee: BEIJING BIO-TARGETING THERAPEUTICS TECHNOLOGY INC.
- Current Assignee Address: CN Beijing
- Agency: Matthias Scholl P.C.
- Agent Matthias Scholl
- Priority: CN201110143385 20110531
- Main IPC: A61K35/761
- IPC: A61K35/761 ; C12N15/86 ; C12N15/861 ; C12N7/00
Abstract:
A subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1), which is constructed by a method including: substituting a 365 bp fragment containing an enhancer and a promoter of an upstream coding sequence of Ad5 E1A (SEQ ID NO: 2) for a corresponding region of a serotype Ad11 (SEQ ID NO: 3) of a subgroup B human adenovirus vector by homologous recombination to construct the subgroup B recombinant human adenovirus vector Ad11-5EP (SEQ ID NO: 1).
Public/Granted literature
- US20180187214A1 SUBGROUP B RECOMBINANT HUMAN ADENOVIRUS VECTOR, AND METHODS FOR CONSTRUCTING AND FOR USING THE SAME Public/Granted day:2018-07-05
Information query
